What can we learn from drug marketing efficiency?
04 december 2008
The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies' techniques could be used to improve safety surveillance systems.
Bron: BMJ (registratie verplicht voor volledige tekst)
| < Vorige | Volgende > |
|---|
